MedTrace Logo

The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System

NCT00486226 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2018-12-12

Study results available
· View outcomes & findings →

Summary

The objective of the registry is to evaluate the real world safety and performance of the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System (VRD) to facilitate endovascular coil embolization of intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Vascular Reconstruction Device

CORDIS ENTERPRISE™ VRD

Sponsors & Collaborators

  • Codman & Shurtleff

    lead INDUSTRY

Principal Investigators

  • Bendszus Martin, MD · Wuerzburg University Hospital

  • Boris Lubicz, MD · Université Libre de Bruxelles

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-01
Primary Completion
2012-12-01
Completion
2013-12-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00486226 on ClinicalTrials.gov